The ongoing conflict between the United States and Israel against Iran is elevating pressure on Brazil's already precarious supply chain for medicines and hospital inputs. This situation follows a trend heightened by tariffs introduced by former President Donald Trump, which negatively impacted the availability of these essential materials. Brazilian associations have noted logistical concerns, given that the country is heavily dependent on pharmaceutical inputs sourced from Asia, with estimations suggesting that between 85% to 95% of active pharmaceutical ingredients (APIs) are imported, primarily relying on routes through the Middle East.